Temat: "Combined Modality Therapy" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study.
Autorzy:: Burkon P; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Selingerova I; Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic. .; Department of Mathematics and Statistics, Faculty of Science, Masaryk University, Brno, Czech Republic. .
Slavik M; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Holanek M; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Vrzal M; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Coufal O; Department of Surgical Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Department of Surgical Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Polachova K; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Muller P; Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
Slampa P; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Kazda T; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.; Pokaż więcej
Źródło:: Radiation oncology (London, England) [Radiat Oncol] 2024 Feb 03; Vol. 19 (1), pp. 17. Date of Electronic Publication: 2024 Feb 03.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Breast Neoplasms*/radiotherapy
Breast Neoplasms*/surgery
Breast Neoplasms*/pathology
Humans ; Infant ; Child, Preschool ; Female ; Quality of Life ; Prospective Studies ; Mastectomy ; Combined Modality Therapy ; Mastectomy, Segmental

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: A systematic review of reviews.
Autorzy:: Todd A; Newcastle University, Newcastle upon Tyne, UK.
Waldron C; Royal College of Surgeons in Ireland, Dublin, Ireland.
McGeagh L; Oxford Brookes University, Oxford, UK.
Norris R; Newcastle University, Newcastle upon Tyne, UK.
Bolnykh I; Newcastle University, Newcastle upon Tyne, UK.; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Stewart SJ; University College London, London, UK.
Slodkowska-Barabasz J; Oxford Brookes University, Oxford, UK.
Moon Z; University College London, London, UK.
Cahir C; Royal College of Surgeons in Ireland, Dublin, Ireland.
Thompson S; Newcastle University, Newcastle upon Tyne, UK.
Harmer V; Imperial College Healthcare NHS Trust, London, UK.
Wells M; Imperial College Healthcare NHS Trust, London, UK.
Watson E; Oxford Brookes University, Oxford, UK.
Sharp L; Newcastle University, Newcastle upon Tyne, UK.; Pokaż więcej
Corporate Authors:: SWEET Research Team
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6937. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Breast Neoplasms*/drug therapy
Female ; Humans ; Breast ; Combined Modality Therapy ; Economic Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Hormone, Targeted, and Combinational Therapies for Breast Cancers: From Humans to Dogs.
Autorzy:: Ke CH; Sustainable Swine Research Center, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan.; Animal Disease Diagnostic Center, College of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan.
Lin CN; Sustainable Swine Research Center, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan.; Animal Disease Diagnostic Center, College of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan.; Department of Veterinary Medicine, College of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan.
Lin CS; Department of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 05; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:: Systematic Review; Journal Article; Review
MeSH Terms:: Breast Neoplasms*/drug therapy
Humans ; Dogs ; Female ; Animals ; Prospective Studies ; Combined Modality Therapy ; Antibodies, Monoclonal/therapeutic use ; Hormones

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Unveiling the Immune Microenvironment's Role in Breast Cancer: A Glimpse into Promising Frontiers.
Autorzy:: Kotsifaki A; Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Alevizopoulos N; Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Dimopoulou V; Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Armakolas A; Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Oct 18; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Breast Neoplasms*/pathology
Humans ; Female ; Lymphocytes, Tumor-Infiltrating ; Combined Modality Therapy ; Cytokines ; Tumor Microenvironment ; Immunotherapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: The impact of preexisting comorbidities on receipt of cancer therapy among women with Stage I-III breast cancer in the Detroit Research on Cancer Survivors cohort.
Autorzy:: Raychaudhuri S; Department of Medical Oncology/Hematology, University of Pittsburgh, Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
Kyko JM; Department of Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan, USA.
Ruterbusch JJ; Department of Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan, USA.
Pandolfi SS; Department of Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan, USA.
Beebe-Dimmer JL; Department of Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan, USA.; Population Studies and Disparities Research Program, Karmanos Cancer Institute, Detroit, Michigan, USA.
Schwartz AG; Department of Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan, USA.; Population Studies and Disparities Research Program, Karmanos Cancer Institute, Detroit, Michigan, USA.
Simon MS; Department of Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan, USA.; Population Studies and Disparities Research Program, Karmanos Cancer Institute, Detroit, Michigan, USA.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (18), pp. 19021-19032. Date of Electronic Publication: 2023 Aug 11.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/therapy
Breast Neoplasms*/drug therapy
Cancer Survivors*
Humans ; Female ; Retrospective Studies ; Combined Modality Therapy ; Comorbidity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Survey of clinicians on the use of adjuvant therapy for premenopausal women with breast cancer.
Autorzy:: Lee YW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Ahn SH; Department of Surgery, Ewha Womans University College of Medicine, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.
Lee YJ; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Yoo TK; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Kim J; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Chung IY; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Ko BS; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Son BH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Lee SB; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Aug 17; Vol. 18 (8), pp. e0290174. Date of Electronic Publication: 2023 Aug 17 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Humans ; Female ; Aged ; Adult ; Middle Aged ; Ki-67 Antigen ; Combined Modality Therapy ; Chemotherapy, Adjuvant ; Tamoxifen/therapeutic use ; Aromatase Inhibitors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer.
Autorzy:: Foldi J; Section of Medical Oncology, Yale School of Medicine, New Haven, CT, 06510, USA. .; Division of Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA. .
Tsagianni A; Division of Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
Salganik M; Biotheranostics Inc, A Hologic Company, San Diego, CA, 92121, USA.
Schnabel CA; Biotheranostics Inc, A Hologic Company, San Diego, CA, 92121, USA.
Brufsky A; Division of Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
van Londen GJ; Division of Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
Pusztai L; Section of Medical Oncology, Yale School of Medicine, New Haven, CT, 06510, USA.
Sanft T; Section of Medical Oncology, Yale School of Medicine, New Haven, CT, 06510, USA. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Jun 30; Vol. 23 (1), pp. 606. Date of Electronic Publication: 2023 Jun 30.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Brain-Computer Interfaces*
Humans ; Female ; Adjuvants, Immunologic ; Combined Modality Therapy ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Less necessity of adjuvant S-1 treatment in non-monarchE-eligible patients.
Autorzy:: Yu M; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Takada M; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yamada H; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Fujimoto H; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Sakakibara J; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yamamoto H; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nagashima T; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Ohtsuka M; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (12), pp. 13193-13203. Date of Electronic Publication: 2023 May 10.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Neoplasm Recurrence, Local*/drug therapy
Breast Neoplasms*
Humans ; Female ; Retrospective Studies ; Prognosis ; Combined Modality Therapy ; Chemotherapy, Adjuvant

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Machine learning survival models trained on clinical data to identify high risk patients with hormone responsive HER2 negative breast cancer.
Autorzy:: Fanizzi A; Struttura Semplice Dipartimentale di Fisica Sanitaria, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy.
Pomarico D; Struttura Semplice Dipartimentale di Fisica Sanitaria, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy.
Rizzo A; Struttura Semplice Dipartimentale di Oncologia Per la Presa in Carico Globale del Paziente Oncologico 'Don Tonino Bello', I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy.
Bove S; Struttura Semplice Dipartimentale di Fisica Sanitaria, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy. .
Comes MC; Struttura Semplice Dipartimentale di Fisica Sanitaria, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy. .
Didonna V; Struttura Semplice Dipartimentale di Fisica Sanitaria, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy.
Giotta F; Unità Operativa Complessa di Oncologia Medica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy.
La Forgia D; Struttura Semplice Dipartimentale di Radiologia Senologica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy.
Latorre A; Unità Operativa Complessa di Oncologia Medica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy.
Pastena MI; Unità Operativa Complessa di Anatomia Patologica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy.
Petruzzellis N; Struttura Semplice Dipartimentale di Fisica Sanitaria, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy.
Rinaldi L; Struttura Semplice Dipartimentale di Oncologia Per la Presa in Carico Globale del Paziente Oncologico 'Don Tonino Bello', I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy.
Tamborra P; Struttura Semplice Dipartimentale di Fisica Sanitaria, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy.
Zito A; Unità Operativa Complessa di Anatomia Patologica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy.
Lorusso V; Unità Operativa Complessa di Oncologia Medica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy.
Massafra R; Struttura Semplice Dipartimentale di Fisica Sanitaria, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 May 26; Vol. 13 (1), pp. 8575. Date of Electronic Publication: 2023 May 26.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Female ; Humans ; Combined Modality Therapy ; Hormones ; Prognosis ; Proportional Hazards Models ; Receptor, ErbB-2/genetics ; Machine Learning

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Intraoperative Radiation Therapy: A Large Integrated Health Care System's Approach and Outcomes.
Autorzy:: Tang A; Department of Surgery, University of California San Francisco, Oakland, CA, USA.
Dzubnar JM; Department of Surgery, University of California San Francisco, Oakland, CA, USA.
Kelly JF; Department of Radiation Oncology, Kaiser Permanente Northern California, Oakland, CA, USA.
Banks KC; Department of Surgery, University of California San Francisco, Oakland, CA, USA.
Phillips JL; Department of Surgery, University of California San Francisco, Oakland, CA, USA.
Cureton EA; Department of Surgery, Kaiser Permanente Northern California, Oakland, CA, USA.
Svahn JD; Department of Surgery, Kaiser Permanente Northern California, Oakland, CA, USA.
Mai V; Department of Surgery, University of California San Francisco, Oakland, CA, USA.
Lyon LL; The Kaiser Permanente Northern California Division of Research, Oakland, CA, USA.
Thomas ES; Department of Medical Oncology, Kaiser Permanente Northern California, Oakland, CA, USA.
Shim VC; Department of Surgery, Kaiser Permanente Northern California, Oakland, CA, USA.; Pokaż więcej
Źródło:: The Permanente journal [Perm J] 2023 Mar 15; Vol. 27 (1), pp. 45-55. Date of Electronic Publication: 2023 Mar 06.
Typ publikacji:: Journal Article
MeSH Terms:: Delivery of Health Care, Integrated*
Breast Neoplasms*/radiotherapy
Breast Neoplasms*/surgery
Humans ; Aged ; Female ; Neoplasm Recurrence, Local/epidemiology ; Mastectomy, Segmental ; Combined Modality Therapy

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Bilateral primary angiosarcoma of the breast: a case report.
Autorzy:: Ooe Y; Department of Breast Surgery, Kanazawa University Hospital, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan. .; Breast Center, Kanazawa University Hospital, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan. .
Terakawa H; Department of Breast Surgery, Kanazawa University Hospital, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.; Breast Center, Kanazawa University Hospital, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.
Kawashima H; Breast Center, Kanazawa University Hospital, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.
Ikeda H; Department of Diagnostic Pathology, Kanazawa University Hospital, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.
Inaki N; Department of Gastrointestinal Surgery/Breast Surgery, Kanazawa University Hospital, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2023 Feb 21; Vol. 17 (1), pp. 60. Date of Electronic Publication: 2023 Feb 21.
Typ publikacji:: Case Reports; Review; Journal Article
MeSH Terms:: Hemangiosarcoma*/diagnostic imaging
Hemangiosarcoma*/therapy
Breast Neoplasms*/pathology
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/therapy
Liver Neoplasms*/complications
Female ; Humans ; Adult ; Combined Modality Therapy
SCR Disease Name:: Angiosarcoma of the breast

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Proteogenomics decodes the evolution of human ipsilateral breast cancer.
Autorzy:: De Marchi T; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden. tommaso.de_.
Pyl PT; Department of Laboratory Medicine, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Lund, Sweden.
Sjöström M; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden.; Department of Radiation Oncology, University of California San Francisco, San Francisco, USA.
Reinsbach SE; Department of Biology and Biological Engineering, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Chalmers University of Technology, Gothenburg, Sweden.
DiLorenzo S; National Bioinformatics Infrastructure Sweden, Uppsala University, Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala, Sweden.
Nystedt B; National Bioinformatics Infrastructure Sweden, Uppsala University, Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala, Sweden.
Tran L; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden.
Pekar G; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Skåne University Hospital, Lund, Sweden.
Wärnberg F; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Fredriksson I; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm, Sweden.
Malmström P; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden.; Department of Haematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund, Sweden.
Fernö M; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden.
Malmström L; Department of Clinical Sciences Lund, Division of Infection Medicine, Faculty of Medicine, Lund University, Lund, Sweden.
Malmstöm J; Department of Clinical Sciences Lund, Division of Infection Medicine, Faculty of Medicine, Lund University, Lund, Sweden.
Niméus E; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden. .; Department of Surgery, Skåne University Hospital, Lund, Sweden. .; Pokaż więcej
Źródło:: Communications biology [Commun Biol] 2023 Feb 02; Vol. 6 (1), pp. 139. Date of Electronic Publication: 2023 Feb 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Proteogenomics*
Mammary Neoplasms, Animal*
Humans ; Animals ; Female ; Mastectomy, Segmental ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Combined Modality Therapy ; Cytidine Deaminase ; Minor Histocompatibility Antigens

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: A case report: Secondary cancers due to oncological treatment modalities.
Autorzy:: Gulmez A; Oncology Department, Inonu University Medical, Malatya, Turkey.; Pokaż więcej
Źródło:: Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Jan-Mar; Vol. 19 (2), pp. 493-497.
Typ publikacji:: Case Reports
MeSH Terms:: Antineoplastic Agents*/therapeutic use
Breast Neoplasms*/drug therapy
Neoplasms, Second Primary*/diagnosis
Neoplasms, Second Primary*/etiology
Neoplasms, Second Primary*/therapy
Humans ; Adult ; Female ; Quality of Life ; Combined Modality Therapy ; Chemotherapy, Adjuvant

Raport

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Interventional oncological treatment of breast cancer liver metastasis (BCLM): single center long-term evaluation over 26 years using thermoablation techniques like LITT, MWA and TACE in a multimodal application.
Autorzy:: Vogl TJ; Diagnostic and Interventional Radiology, Frankfurt University Hospital Frankfurt, Frankfurt am Main, Germany.
Freichel J; Diagnostic and Interventional Radiology, Frankfurt University Hospital Frankfurt, Frankfurt am Main, Germany.
Gruber-Rouh T; Diagnostic and Interventional Radiology, Frankfurt University Hospital Frankfurt, Frankfurt am Main, Germany.
Nour Eldin NE; Diagnostic and Interventional Radiology, Frankfurt University Hospital Frankfurt, Frankfurt am Main, Germany.; Department of Diagnostic and Interventional Radiology, Cairo University, Cairo, Egypt.
Becker S; Department of Obstetrics & Gynaecology, Frankfurt University Hospital Frankfurt, Frankfurt am Main, Germany.
Solbach C; Department of Obstetrics & Gynaecology, Goethe University Hospital Frankfurt, Frankfurt am Main, Germany.
Stefenelli U; Statistical Analysis Dr. Stefenelli, Untere Bockgasse 5, Wurzburg, Germany.
Naguib NNN; Radiology Department, AMEOS Hospital Halberstadt, Halberstadt, Germany.; Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.; Pokaż więcej
Źródło:: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2200582.
Typ publikacji:: Journal Article
MeSH Terms:: Liver Neoplasms*/pathology
Carcinoma, Hepatocellular*/surgery
Breast Neoplasms*/therapy
Chemoembolization, Therapeutic*/methods
Humans ; Female ; Retrospective Studies ; Combined Modality Therapy ; Treatment Outcome ; Melanoma, Cutaneous Malignant

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Optimizing Adjuvant Treatment Recommendations for Older Women with Biologically Favorable Breast Cancer: Short-Course Radiation or Long-Course Endocrine Therapy?
Autorzy:: McDuff SGR; Department of Radiation Oncology, Duke Cancer Center, Durham, NC 27710, USA.
Blitzblau RC; Department of Radiation Oncology, Duke Cancer Center, Durham, NC 27710, USA.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Dec 27; Vol. 30 (1), pp. 392-400. Date of Electronic Publication: 2022 Dec 27.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Breast Neoplasms*/drug therapy
Humans ; Female ; Aged ; Combined Modality Therapy ; Radiotherapy, Adjuvant

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Radiation in Early-Stage Breast Cancer: Moving beyond an All or Nothing Approach.
Autorzy:: Purswani JM; Department of Radiation Oncology, NYU Grossman School of Medicine, New York, NY 10016, USA.
Hardy-Abeloos C; Department of Radiation Oncology, NYU Grossman School of Medicine, New York, NY 10016, USA.
Perez CA; Department of Radiation Oncology, NYU Grossman School of Medicine, New York, NY 10016, USA.
Kwa MJ; Department of Medical Oncology, NYU Grossman School of Medicine, New York, NY 10016, USA.
Chadha M; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Gerber NK; Department of Radiation Oncology, NYU Grossman School of Medicine, New York, NY 10016, USA.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Dec 23; Vol. 30 (1), pp. 184-195. Date of Electronic Publication: 2022 Dec 23.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Breast Neoplasms*/pathology
Humans ; Female ; Mastectomy, Segmental ; Combined Modality Therapy ; Patient Selection

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Preoperative Radio(Chemo)Therapy in Breast Cancer: Time to Switch the Perspective?
Autorzy:: Montero A; Department of Radiation Oncolo Gy, HM Sanchinarro University Hospital, HM Hospitales, 28050 Madrid, Spain.
Ciérvide R; Department of Radiation Oncolo Gy, HM Sanchinarro University Hospital, HM Hospitales, 28050 Madrid, Spain.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Dec 12; Vol. 29 (12), pp. 9767-9787. Date of Electronic Publication: 2022 Dec 12.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/pathology
Antineoplastic Agents*/therapeutic use
Humans ; Female ; Neoadjuvant Therapy ; Combined Modality Therapy ; Disease-Free Survival

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: The VES-13 and G-8 tools as predictors of toxicity associated with aromatase inhibitors in the adjuvant treatment of breast cancer in elderly patients: A single-center study.
Autorzy:: Irelli A; Medical Oncology Unit, Department of Oncology, AUSL 04 Teramo, Italy.
Sirufo MM; Department of Life, Health and Environmental Sciences, University of L'Aquila; Allergy and Clinical Immunology Unit, Center for the Diagnosis and Treatment of Osteoporosis, AUSL 04 Teramo, Italy.
Scipioni T; Medical Oncology Unit, Department of Oncology, AUSL 04 Teramo, Italy.
Aielli F; Medical Oncology Unit, Department of Oncology, AUSL 04 Teramo, Italy.
Martella F; Medical Oncology Unit, Department of Oncology, AUSL 04 Teramo, Italy.
Ginaldi L; Department of Life, Health and Environmental Sciences, University of L'Aquila; Allergy and Clinical Immunology Unit, Center for the Diagnosis and Treatment of Osteoporosis, AUSL 04 Teramo, Italy.
Pancotti A; Medical Oncology Unit, Department of Oncology, AUSL 04 Teramo, Italy.
Martinis M; Department of Life, Health and Environmental Sciences, University of L'Aquila; Allergy and Clinical Immunology Unit, Center for the Diagnosis and Treatment of Osteoporosis, AUSL 04 Teramo, Italy.; Pokaż więcej
Źródło:: Indian journal of cancer [Indian J Cancer] 2022 Oct-Dec; Vol. 59 (4), pp. 485-492.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Aged ; Humans ; Female ; Aromatase Inhibitors/adverse effects ; Combined Modality Therapy ; Patients ; Medical Oncology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Current Molecular Combination Therapies Used for the Treatment of Breast Cancer.
Autorzy:: Wang Y; Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Minden A; Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Sep 20; Vol. 23 (19). Date of Electronic Publication: 2022 Sep 20.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*
Combined Modality Therapy ; Female ; Hormones/therapeutic use ; Humans ; Immunotherapy ; Neoplasm Recurrence, Local

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: A machine learning ensemble approach for 5- and 10-year breast cancer invasive disease event classification.
Autorzy:: Massafra R; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Comes MC; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Bove S; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Didonna V; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Diotaiuti S; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Giotta F; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Latorre A; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
La Forgia D; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Nardone A; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Pomarico D; Dipartimento di Fisica and MECENAS, Università di Bari, Bari, Italy.; INFN, Sezione di Bari, Bari, Italy.
Ressa CM; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Rizzo A; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Tamborra P; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Zito A; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Lorusso V; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Fanizzi A; I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Sep 19; Vol. 17 (9), pp. e0274691. Date of Electronic Publication: 2022 Sep 19 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/pathology
Combined Modality Therapy ; Female ; Humans ; Italy ; Machine Learning

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Combined Modality Therapy"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język